Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christophe Massard
ODM-201, a New Generation Androgen Receptor Inhibitor for Castration-Resistant Prostate Cancer: Preclinical and Phase I Data.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
High-Throughput Genomics and Clinical Outcome in Hard-To-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Cancer Discovery
Oncology
Long-Term Survival in Patients Responding to Anti-Pd-1/Pd-L1 Therapy and Disease Outcome Upon Treatment Discontinuation
Clinical Cancer Research
Cancer Research
Oncology
Time to Progression Ratio in Cancer Patients Enrolled in Early Phase Clinical Trials: Time for New Guidelines?
British Journal of Cancer
Cancer Research
Oncology
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-Naïve and CYP17 Inhibitor-Naïve Patients: Follow-Up From the ARADES and ARAFOR Trials
European Urology Focus
Urology
Efficacy of Histology-Agnostic and Molecularly-Driven HER2 Inhibitors for Refractory Cancers
Oncotarget
Oncology
Helping Patients Make Informed Decisions. Two-Year Evaluation of the Gustave Roussy Prostate Cancer Multidisciplinary Clinic
Clinical and Translational Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Durvalumab for the Management of Urothelial Carcinoma: A Short Review on the Emerging Data and Therapeutic Potential
OncoTargets and Therapy
Oncology
Pharmacology
First-In-Human Phase I Study of a Dual mTOR Kinase and DNA-PK Inhibitor (CC-115) in Advanced Malignancy
Cancer Management and Research
Oncology
Environmental Toxicity and Antimicrobial Efficiency of Titanium Dioxide Nanoparticles in Suspension
Journal of Biomaterials and Nanobiotechnology